Thus, these two prostate cancer cell lines exhibit distinct, PCa-specific PSA promoter methylation statuses, potentially linked to a loss of imprinting (LOI) if monoallelic PSA expression regulation by imprinting is assumed. The gene discussed is KLK3; the disease is prostate cancer.